Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury

Cardiovascular Research

Volumn 103, Issue 4, 2014, Pages 564-572

  Daniel, Jan Marcus ^a,b   Penzkofer, Daniela ^c   Teske, Rebecca ^a,b   Dutzmann, Jochen ^a   Koch, Alexander ^a,b   Bielenberg, Wiebke ^a,b   Bonauer, Angelika ^c   Boon, Reinier A ^c   Fischer, Ariane ^c   Bauersachs, Johann ^a   Van Rooij, Eva ^d   Dimmeler, Stefanie ^c   Sedding, Daniel G ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d HUBRECHT INSTITUTE   (Netherlands)

Author keywords

Endothelial cells; MicroRNAs; Neointimal formation; Re endothelialization

Indexed keywords

ALPHA5 INTEGRIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MICRORNA; MICRORNA 92A; SIRTUIN 1; UNCLASSIFIED DRUG; MIRN92 MICRORNA, HUMAN; MIRN92 MICRORNA, MOUSE;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL INJURY; CELL PROLIFERATION; CONTROLLED STUDY; DEFENSE MECHANISM; ENDOTHELIUM CELL; GENE DELETION; HUMAN; HUMAN CELL; LEUKOCYTE; NEOINTIMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REENDOTHELIALIZATION; SMOOTH MUSCLE FIBER; UPREGULATION; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; BIOLOGICAL FUNCTIONS; CELL MIGRATION; GENE OVEREXPRESSION; GENE REPRESSION; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; ANIMAL; CELL CULTURE; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; RNA INTERFERENCE; VASCULAR ENDOTHELIUM;

ANIMALS; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; MICE; MICRORNAS; NEOINTIMA; NEOVASCULARIZATION, PATHOLOGIC; RNA INTERFERENCE; VASCULAR SYSTEM INJURIES;

EID: 84903615620     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu162     Document Type: Article

References (29)

1. Kaiser C, Galatius S, Erne P, Eberli F, Alber H, Rickli H, Pedrazzini G, Hornig B, Bertel O, Bonetti P, De Servi S, Brunner-La Rocca HP, Ricard I, Pfisterer M. Drug-eluting versus bare-metal stents in large coronary arteries. N Engl J Med 2010;363: 2310-2319.
2. Mauri L, Silbaugh TS, Wolf RE, Zelevinsky K, Lovett A, Zhou Z, Resnic FS, Normand SL. Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts. Circulation 2008;118: 1817-1827.
3. Curcio A, Torella D, Indolfi C. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy. Circ J 2011;75: 1287-1296.
4. Bonauer A, Boon RA, Dimmeler S. Vascular microRNAs. Curr Drug Targets 2010;11: 943-949.
5. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, Chavakis E, Potente M, Tjwa M, Urbich C, Zeiher AM, Dimmeler S. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009;324: 1710-1713.
6. Doebele C, Bonauer A, Fischer A, Scholz A, ReissY, Urbich C, HofmannWK, Zeiher AM, Dimmeler S. Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood 2010;115: 4944-4950.
7. Wu W, Xiao H, Laguna-Fernandez A, Villarreal G Jr, Wang KC, Geary GG, Zhang Y, Wang WC, Huang HD, Zhou J, Li YS, Chien S, Garcia-Cardena G, Shyy JY. Flowdependent regulation of Kruppel-like factor 2 is mediated by microRNA-92a. Circulation 2011;124: 633-641.
8. Fang Y, Davies PF. Site-specific microRNA-92a regulation of Kruppel-like factors 4 and 2 in atherosusceptible endothelium. Arterioscler Thromb Vasc Biol 2012;32: 979-987.
9. Sedding DG, Trobs M, Reich F, Walker G, Fink L, HaberboschW, RauW, Tillmanns H, Preissner KT, Bohle RM, Langheinrich AC. 3-Deazaadenosine prevents smooth muscle cell proliferation and neointima formation by interfering with Ras signaling. Circ Res 2009; 104: 1192-1200.
10. Daniel JM, Dutzmann J, Bielenberg W, Widmer-Teske R, Gunduz D, Hamm CW, Sedding DG. Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation. Basic Res Cardiol 2012;107: 1-12.
11. de Boer J, Williams A, Skavdis G, Harker N, Coles M, Tolaini M, Norton T, Williams K, Roderick K, Potocnik AJ, Kioussis D. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur J Immunol 2003;33: 314-325.
12. Daniel JM, BielenbergW, Stieger P, Weinert S, Tillmanns H, SeddingDG. Time-course analysis on the differentiation of bone marrow-derived progenitor cells into smooth muscle cells during neointima formation. Arterioscler Thromb Vasc Biol 2010;30: 1890-1896.
13. Sedding D, Daniel JM, Muhl L, Hersemeyer K, Brunsch H, Kemkes-Matthes B, Braun-Dullaeus RC, Tillmanns H, Weimer T, Preissner KT, Kanse SM. The G534E polymorphism of the gene encoding the factor VII-activating protease is associated with cardiovascular risk due to increased neointima formation. J Exp Med 2006;203: 2801-2807.
14. Lindner V, Fingerle J, Reidy MA. Mouse model of arterial injury. Circ Res 1993;73: 792-796.
15. NamD, NiCW, Rezvan A, Suo J, Budzyn K, Llanos A, Harrison D, Giddens D, Jo H. Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis. Am J Physiol Heart Circ Physiol 2009;297: H1535-H1543.
16. Montgomery RL, van Rooij E. Therapeutic advances in MicroRNA targeting. J Cardiovasc Pharmacol 2011;57: 1-7.
17. Reidy MA. A reassessment of endothelial injury and arterial lesion formation. Lab Invest 1985;53: 513-520.
18. Loyer X, Potteaux S, Vion AC, Guerin CL, Boulkroun S, Rautou PE, Ramkhelawon B, Esposito B, Dalloz M, Paul JL, Julia P, Maccario J, Boulanger CM, Mallat Z, Tedgui A. Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice. Circ Res 2014;114: 434-443.
19. Guarani V, Deflorian G, Franco CA, Kruger M, Phng LK, Bentley K, Toussaint L, Dequiedt F, Mostoslavsky R, Schmidt MH, Zimmermann B, Brandes RP, Mione M, Westphal CH, Braun T, Zeiher AM, Gerhardt H, Dimmeler S, Potente M. Acetylationdependent regulation of endothelial Notch signalling by the SIRT1 deacetylase. Nature 2011;473: 234-238.
20. Zhang QJ, Wang Z, Chen HZ, Zhou S, ZhengW, Liu G, Wei YS, Cai H, Liu DP, Liang CC. Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res 2008;80: 191-199.
21. Li L, Zhang HN, Chen HZ, Gao P, Zhu LH, Li HL, Lv X, Zhang QJ, Zhang R, Wang Z, She ZG, Wei YS, Du GH, Liu DP, Liang CC. SIRT1 acts as a modulator of neointima formation following vascular injury in mice. Circ Res 2011;108: 1180-1189.
22. Koyama H, Reidy MA. Expression of extracellular matrix proteins accompanies lesion growth in a model of intimal reinjury. Circ Res 1998;82: 988-995.
23. Boon RA, Urbich C, Fischer A, Fontijn RD, Seeger FH, Koyanagi M, Horrevoets AJ, Dimmeler S. Kruppel-like factor 2 improves neovascularization capacity of aged proangiogenic cells. Eur Heart J 2011;32: 371-377.
24. Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, SessaWC.Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 1998; 101: 731-736.
25. Ota H, Eto M, Ogawa S, Iijima K, Akishita M, Ouchi Y. SIRT1/eNOS axis as a potential target against vascular senescence, dysfunction and atherosclerosis. J Atheroscler Thromb 2010;17: 431-435.
26. International Stroke Genetics C, Wellcome Trust Case Control C, Bellenguez C, Bevan S, Gschwendtner A, Spencer CC, Burgess AI, Pirinen M, Jackson CA, Traylor M, Strange A, Su Z, Band G, Syme PD, Malik R, Pera J, Norrving B, Lemmens R, Freeman C, Schanz R, James T, Poole D, Murphy L, Segal H, Cortellini L, Cheng YC, Woo D, Nalls MA, Muller-Myhsok B, Meisinger C, Seedorf U, Ross-Adams H, Boonen S, Wloch-Kopec D, Valant V, Slark J, Furie K, Delavaran H, Langford C, Deloukas P, Edkins S, Hunt S, Gray E, Dronov S, Peltonen L, Gretarsdottir S, Thorleifsson G, Thorsteinsdottir U, Stefansson K, Boncoraglio GB, Parati EA, Attia J, Holliday E, Levi C, Franzosi MG, Goel A, Helgadottir A, Blackwell JM, Bramon E, Brown MA, Casas JP, Corvin A, Duncanson A, Jankowski J, Mathew CG, Palmer CN, Plomin R, Rautanen A, Sawcer SJ, Trembath RC, Viswanathan AC, Wood NW, Worrall BB, Kittner SJ, Mitchell BD, Kissela B, Meschia JF, Thijs V, Lindgren A, Macleod MJ, Slowik A, Walters M, Rosand J, Sharma P, Farrall M, Sudlow CL, Rothwell PM, Dichgans M, Donnelly P, Markus HS.Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet 2012; 44: 328-333.
27. Kaluza D, Kroll J, Gesierich S, Manavski Y, Boeckel JN, Doebele C, Zelent A, Rossig L, Zeiher AM, AugustinHG, Urbich C, Dimmeler S. Histone deacetylase 9 promotes angiogenesis by targeting the antiangiogenic microRNA-17-92 cluster in endothelial cells. Arterioscler Thromb Vasc Biol 2013;33: 533-543.
28. Hinkel R, Penzkofer D, Zuhlke S, Fischer A, Husada W, Xu QF, Baloch E, van Rooij E, Zeiher AM, Kupatt C, Dimmeler S. Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model. Circulation 2013;128: 1066-1075.
29. Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, van der Meer AJ, Patick AK, Chen A, Zhou Y, Persson R, King BD, Kauppinen S, Levin AA, Hodges MR. Treatment of HCV infection by targeting microRNA. N Engl J Med 2013; 368: 1685-1694.